TYROSINE KINASE INHIBITORS (TKI) FOR THE TREATMENT OF ADVANCED MEDULLARY THYROID CARCINOMA: A SYSTEMATIC REVIEW AND INDIRECT COMPARISON

被引：0
|
作者：
Kawalec, P. [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN4
引用
收藏
页码：A708 / A708
页数：1
相关论文
共 50 条
  • [41] Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
    Mário Fontes-Sousa
    Helena Magalhães
    Alicia Oliveira
    Filipa Carneiro
    Filipa Palma dos Reis
    Pedro Silvestre Madeira
    Sara Meireles
    Advances in Therapy, 2022, 39 : 1107 - 1125
  • [42] Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
    Fontes-Sousa, Mario
    Magalhaes, Helena
    Oliveira, Alicia
    Carneiro, Filipa
    dos Reis, Filipa Palma
    Madeira, Pedro Silvestre
    Meireles, Sara
    ADVANCES IN THERAPY, 2022, 39 (03) : 1107 - 1125
  • [43] USE OF TYROSINE KINASE INHIBITORS (TKI) IN HAEMODIALYTIC METASTATIC RENAL CELL CARCINOMA PATIENTS
    Sabbatini, R.
    Porta, C.
    Procopio, G.
    Ferrari, A.
    Conte, P. F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 185 - 185
  • [44] The Effects of Four Different Tyrosine Kinase Inhibitors on Medullary and Papillary Thyroid Cancer Cells
    Verbeek, Hans H. G.
    Alves, Maria M.
    de Groot, Jan-Willem B.
    Osinga, Jan
    Plukker, John T. M.
    Links, Thera P.
    Hofstra, Robert M. W.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (06): : E991 - E995
  • [45] Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer
    Lin, Chi-Iou
    Whang, Edward E.
    Lorch, Jochen H.
    Ruan, Daniel T.
    SURGERY, 2012, 152 (06) : 1142 - 1149
  • [46] Tyrosine kinase inhibitors and modifications of thyroid function tests: a review
    Illouz, Frederic
    Laboureau-Soares, Sandrine
    Dubois, Severine
    Rohmer, Vincent
    Rodien, Patrice
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (03) : 331 - 336
  • [47] Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update
    Nervo, Alice
    Retta, Francesca
    Ragni, Alberto
    Piovesan, Alessandro
    Mella, Alberto
    Biancone, Luigi
    Manganaro, Marco
    Gallo, Marco
    Arvat, Emanuela
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [48] Medullary carcinoma of the thyroid: Review of treatment and prognosis.
    Hyer, SL
    Vini, L
    A'Hern, R
    Harmer, C
    BRITISH JOURNAL OF CANCER, 1999, 80 : 112 - 112
  • [49] Emerging tyrosine kinase inhibitors for the treatment of hepatocellular carcinoma
    de Rosamel, Laure
    Blanc, Jean-Frederic
    EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (02) : 175 - 190
  • [50] Tracheoesophageal fistula development following radiotherapy and tyrosine kinase inhibitors in a patient with advanced follicular thyroid carcinoma: a case-based review
    Temperley, Tatiana S.
    Temperley, Hugo C.
    O'Sullivan, Niall J.
    Corr, Alison
    Brennan, Ian
    Kelly, Michael E.
    Prior, Lisa
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 (03) : 1143 - 1147
12345